Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evolution of HER2-low expression from primary to recurrent breast cancer.
Miglietta F, Griguolo G, Bottosso M, Giarratano T, Lo Mele M, Fassan M, Cacciatore M, Genovesi E, De Bartolo D, Vernaci G, Amato O, Conte P, Guarneri V, Dieci MV. Miglietta F, et al. Among authors: genovesi e. NPJ Breast Cancer. 2021 Oct 12;7(1):137. doi: 10.1038/s41523-021-00343-4. NPJ Breast Cancer. 2021. PMID: 34642348 Free PMC article.
Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer.
Miglietta F, Dieci MV, Tsvetkova V, Griguolo G, Vernaci G, Menichetti A, Faggioni G, Giarratano T, Mioranza E, Genovesi E, Cumerlato E, Bottosso M, Saibene T, Michieletto S, Lo Mele M, Conte P, Guarneri V. Miglietta F, et al. Among authors: genovesi e. Oncologist. 2020 Sep;25(9):e1355-e1362. doi: 10.1634/theoncologist.2020-0201. Epub 2020 Jul 21. Oncologist. 2020. PMID: 32618068 Free PMC article.
Everolimus plus aromatase inhibitors as maintenance therapy after first-line chemotherapy: Final results of the phase III randomised MAIN-A (MAINtenance Afinitor) trial.
Guarneri V, Giorgi CA, Cinieri S, Bengala C, Mariani G, Bisagni G, Frassoldati A, Zamagni C, De Rossi C, Amoroso V, Andreetta C, Ferro A, Zambelli A, Gori S, Garrone O, Dieci MV, Orlando L, Pastina I, Beninato T, Moretti G, Genovesi E, Cinefra M, Vicini R, Magni G, De Salvo GL, Conte P. Guarneri V, et al. Among authors: genovesi e. Eur J Cancer. 2021 Sep;154:21-29. doi: 10.1016/j.ejca.2021.05.008. Epub 2021 Jul 2. Eur J Cancer. 2021. PMID: 34225066 Free article. Clinical Trial.
Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant/adjuvant chemotherapy.
Dieci MV, Griguolo G, Bottosso M, Tsvetkova V, Giorgi CA, Vernaci G, Michieletto S, Angelini S, Marchet A, Tasca G, Genovesi E, Cumerlato E, Lo Mele M, Conte P, Guarneri V. Dieci MV, et al. Among authors: genovesi e. NPJ Breast Cancer. 2021 Aug 2;7(1):101. doi: 10.1038/s41523-021-00308-7. NPJ Breast Cancer. 2021. PMID: 34341356 Free PMC article.
Author Correction: Evolution of HER2-low expression from primary to recurrent breast cancer.
Miglietta F, Griguolo G, Bottosso M, Giarratano T, Lo Mele M, Fassan M, Cacciatore M, Genovesi E, De Bartolo D, Vernaci G, Amato O, Conte P, Guarneri V, Dieci MV. Miglietta F, et al. Among authors: genovesi e. NPJ Breast Cancer. 2021 Nov 24;7(1):149. doi: 10.1038/s41523-021-00359-w. NPJ Breast Cancer. 2021. PMID: 34819500 Free PMC article. No abstract available.
HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatment.
Miglietta F, Griguolo G, Bottosso M, Giarratano T, Lo Mele M, Fassan M, Cacciatore M, Genovesi E, De Bartolo D, Vernaci G, Amato O, Porra F, Conte P, Guarneri V, Dieci MV. Miglietta F, et al. Among authors: genovesi e. NPJ Breast Cancer. 2022 May 20;8(1):66. doi: 10.1038/s41523-022-00434-w. NPJ Breast Cancer. 2022. PMID: 35595761 Free PMC article.
Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation.
Dieci MV, Carbognin L, Miglietta F, Canino F, Giorgi CA, Cumerlato E, Amato O, Massa D, Griguolo G, Genovesi E, Garufi G, Giannarelli D, Tornincasa A, Trudu L, Michieletto S, Saibene T, Lo Mele M, Fassan M, Zarrilli G, Piacentini F, Bria E, Guarneri V. Dieci MV, et al. Among authors: genovesi e. Br J Cancer. 2023 Jan;128(2):266-274. doi: 10.1038/s41416-022-02050-8. Epub 2022 Nov 17. Br J Cancer. 2023. PMID: 36396818 Free PMC article.
Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation.
Dieci MV, Carbognin L, Miglietta F, Canino F, Giorgi CA, Cumerlato E, Amato O, Massa D, Griguolo G, Genovesi E, Garufi G, Giannarelli D, Tornincasa A, Trudu L, Michieletto S, Saibene T, Lo Mele M, Fassan M, Zarrilli G, Piacentini F, Bria E, Guarneri V. Dieci MV, et al. Among authors: genovesi e. Br J Cancer. 2023 Jan;128(2):398. doi: 10.1038/s41416-022-02087-9. Br J Cancer. 2023. PMID: 36460777 Free PMC article. No abstract available.
Stalactites in the Right Ventricle.
Genovesi E, Di Marino M, Di Marco M, Gallina S, Galanti K, Paloscia L. Genovesi E, et al. J Cardiovasc Echogr. 2023 Oct-Dec;33(4):199-201. doi: 10.4103/jcecho.jcecho_46_23. Epub 2024 Feb 26. J Cardiovasc Echogr. 2023. PMID: 38486687 Free PMC article.
68 results